Published in Cancer Weekly, May 19th, 2009
"Histological preparations were used to measure depth of mesorectal invasion, which was analyzed for associations with disease-free survival and recurrence. Five-year overall survival and disease-free survival were 64.8% and 57.1%, respectively. Ten patients developed recurrent disease;...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.